Ciltacabtagene Autoleucel-Induced Delayed Neurotoxicity: Insights from a Rural Population with 100% Treatment Response Rate

Key Points

• Delayed neurotoxicity was observed in the rural population receiving ciltacabtagene autoleucel treatment, raising concerns.
• The treatment showed a remarkable 100% response rate, emphasizing its effectiveness under specific conditions.
• This analysis included individuals within a rural setting, highlighting the need for tailored monitoring strategies.
• Understanding these neurotoxic effects may inform future clinical practices and patient management.